温通贴治疗原发性痛经的入血成分、网络药理学与转录组学机制研究
本研究采用UPLC-Q-Exactive Orbitrap-MS检测温通贴入血成分,通过扭体反应、病理分析及雌激素、一氧化氮、孕酮等指标评价其对原发性痛经的治疗作用,并结合网络药理学与转录组学阐明机制。结果显示检测到49种原形成分入血,温通贴上调NO、下调PGF2α、PGE2、雌激素和孕酮水平,并通过调控IL-17信号通路(下调Cxcl6和IL-17、上调Lcn2)减轻炎症治疗痛经。
要点
- 温通贴可上调NO、下调PGF2α、PGE2、雌激素和孕酮,改善血流并抑制扭体反应。
- 温通贴通过下调Cxcl6和IL-17、上调Lcn2调控IL-17信号通路减轻炎症。
- 检测到49种温通贴原形成分入血,为其机制研究提供物质基础。
核心结论
- 温通贴主要通过下调Cxcl6和IL-17、上调Lcn2表达,调控IL-17信号通路减轻炎症,从而治疗原发性痛经。
研究设计与样本
- 采用UPLC-Q-Exactive Orbitrap-MS检测温通贴入血成分,通过扭体反应、病理分析及雌激素、NO、孕酮等指标评价疗效,并结合网络药理学与转录组学阐明机制,最后用ELISA和Western blotting验证相关指标。
主要发现
- 检测到49种温通贴原形成分入血。
- 温通贴上凋NO水平,下调PGF2α、PGE2、雌激素和孕酮水平,从而增加血流、减轻炎症反应并抑制扭体反应。
- 网络药理学与转录组学分析表明温通贴可上调Lcn2表达、下调Cxcl6和IL-17表达,调控IL-17信号通路减轻炎症。
临床怎么用
- 温通贴可能通过调控IL-17信号通路减轻炎症来治疗原发性痛经,为临床应用于PD提供参考依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Primary dysmenorrhea (PD) is characterized by pain during the menstrual cycle, affects women's health. Our group developed a traditional Chinese medicine plaster (Wentong plaster, WTT) for the treatment of PD. However, the underlying mechanisms have not yet been elucidated. METHODS: In this study, the blood-entry components of WTT were detected using UPLC-Q-Exactive Orbitrap-MS, and the therapeutic functions of WTT on PD were evaluated by the writhing response, pathological analysis, and the levels of estrogen, nitric oxide, progesterone, among other indicators. Network pharmacology and transcriptomics were used to elucidate the underlying mechanisms. Finally, enzyme-linked immunosorbent assay and western blotting were used to determine the levels of relevant indicators. RESULTS: Our findings indicate that 49 original blood-entry components were detected. Meanwhile, WTT upregulated the level of NO, and downregulated the levels of PGF2α, PGE2, estrogen, and progesterone, thereby increasing blood flow, alleviating inflammatory responses, and inhibiting the writhing response. Results from network pharmacology and transcriptomics analyses indicated that WTT could increase the expression of Lcn2 and decrease the expression of Cxcl6 and IL-17, thereby regulating the IL-17 signaling pathway, and alleviating inflammation to treat PD. CONCLUSION: WTT mainly down-regulates the levels of Cxcl6 and IL-17 and up-regulates the expression of Lcn2, further regulates the IL-17 signaling pathway to alleviate inflammation, ultimately treating PD. This study provides a basis for further research on the mechanism of WTT, and offers a reference for its clinical application.
引用
- Yang Z, Jiao Z, Wang C, et al. Interaction of blood-entry components, network pharmacology and transcriptomics to elucidate the mechanism of Wentong plaster in treating primary dysmenorrhea. Front Pharmacol. 2025. PMID: 40672364. doi:10.3389/fphar.2025.1591558
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。